Dik van Gent

Dik van Gent is an Associate Professor in the Department of Molecular Genetics at Erasmus MC, where he leads research on DNA damage responses and their application in optimizing cancer treatments. His work focuses on DNA double-strand break repair mechanisms, particularly non-homologous end-joining and homologous recombination, with a strong emphasis on translational applications.

The research interests of Dr. van Gent center on understanding how tumor cells respond to chemotherapy and radiation. His laboratory develops ex vivo functional assays using tumor specimens such as thin tumor slices to predict patient-specific treatment responses. These models are instrumental in advancing personalized oncology and reducing adverse effects in healthy tissues.

Analysis of his recent publications reveals a consistent focus on DNA repair mechanisms, radiosensitivity prediction, and ex vivo modeling in breast, head and neck, and ovarian cancers. His work integrates molecular biology with clinical oncology, often incorporating advanced technologies like deep learning for automated DNA damage detection.

Dr. van Gent has supervised multiple research projects, as indicated by the 'Supervised Work (8)' noted in his profile. He is actively involved in collaborative research across disciplines, including radiation oncology, medical physics, and pharmacology, contributing to both national and international efforts in cancer treatment optimization.

His lab is engaged in developing predictive tests for tumor response to chemotherapy and radiation therapy, particularly through functional assays like the REMIT assay for breast cancer. These initiatives are part of a broader effort to translate molecular insights into clinical practice, improving therapeutic efficacy and patient outcomes.